Position
EVOLUTION WEALTH MANAGEMENT INC. in Amylyx Pharmaceuticals, Inc.
Back to the book · All holders of AMLX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$249$13.59 → $12.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q3 2025 | 165 | $2.24K | — | — | — | 0.0% |
| Q4 2025 | 165 | $1.99K | $12.08 | −$249 | $0 | 0.0% |